Currently approved for treating contagious diarrhea in children, nitazoxanide has been found to make pegylated interferon-based treatment for Hepatitis C genotype 4 more effective. Prompting new trials in the U.S. and Europe, this drug is now being evaluated for Hepatitis...

When tested on those with Hepatitis C genotype 1, polymerase inhibitor R7128 proved to be an effective addition to combination therapy in just four weeks. In addition to its anti-viral effect, R7128 received good marks for safety and minimal side...